Leaflet GRANISETRON KABI 1mg / ml concentrate for solution for injection / infusion


Indicated for: chemotherapy-induced nausea and vomiting

Route of administration: injectable / infusion

Substance: granisetron (antiemetic)

ATC: A04AA02 (Alimentary tract and metabolism | Antiemetics and antinauseants | Serotonin (5ht3) antagonists)

Granisetron is a medication used to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It belongs to a class of drugs known as 5-HT3 receptor antagonists.

This medication works by blocking the action of serotonin, a natural substance in the body that can trigger nausea and vomiting. It is available in tablet form, transdermal patches, or injectable solutions.

Granisetron is generally well-tolerated but may cause side effects such as headaches, constipation, or dizziness. In rare cases, severe allergic reactions may occur.

It is important to use granisetron as directed by your doctor and to inform medical staff about any other medications you are taking to avoid interactions.

General data about GRANISETRON KABI 1mg / ml

  • Substance: granisetron
  • Date of last drug list: 01-04-2014
  • Commercial code: W53853002
  • Concentration: 1mg / ml
  • Pharmaceutical form: concentrate for solution for injection / infusion
  • Packing volume: 1ml
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: LABESFAL-LABORATORIOS ALMIRO S.A. - PORTUGALIA
  • Holder: FRESENIUS KABI ROMANIA S.R.L. - ROMANIA
  • Number: 5462/2013/02
  • Shelf life: 3 years-after packing for marketing; after the first opening-it is used immediately

Concentrations available for granisetron

  • 1mg
  • 1mg/1ml
  • 1mg/ml
  • 20mcg/ml
  • 2mg
  • 3.1mg/24h
  • 3mg/3ml